| Breakdown | Dec 2025 | Dec 2024 | Mar 2024 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 39.26M | 14.94M | 8.69M | 11.04M | 7.75M |
| Gross Profit | 9.87M | 3.47M | -3.34M | 2.00M | 838.61K |
| EBITDA | -8.46M | -1.29M | -5.89M | 1.26M | 825.95K |
| Net Income | -4.34M | -1.73M | -6.35M | 428.66K | -60.47K |
Balance Sheet | |||||
| Total Assets | 153.93M | 34.64M | 28.09M | 34.70M | 35.00M |
| Cash, Cash Equivalents and Short-Term Investments | 30.49M | 18.17M | 11.97M | 19.32M | 21.62M |
| Total Debt | 185.05K | 1.71M | 28.44K | 312.00K | 215.15K |
| Total Liabilities | 12.97M | 6.04M | 2.57M | 2.83M | 2.63M |
| Stockholders Equity | 140.96M | 28.60M | 25.52M | 31.87M | 32.37M |
Cash Flow | |||||
| Free Cash Flow | -37.50M | 1.79M | -6.28M | -1.98M | -3.08M |
| Operating Cash Flow | -9.69M | 2.22M | -4.75M | -249.28K | -2.43M |
| Investing Cash Flow | -87.40M | -42.07K | -1.34M | -1.79M | -653.13K |
| Financing Cash Flow | 109.48M | 4.14M | -1.07M | -267.73K | 23.78M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
58 Neutral | $1.22B | 8.84 | 14.19% | 1.14% | 7.92% | 91.83% | |
53 Neutral | $1.17B | -143.02 | -6.14% | ― | 240.12% | 0.98% | |
50 Neutral | $697.98M | -5.12 | -22.22% | 1.17% | -16.89% | -403.77% | |
49 Neutral | $381.96M | -11.63 | -46.98% | ― | 821.40% | 44.70% | |
47 Neutral | $643.77M | -248.46 | -44.72% | ― | ― | ― |
On March 16, 2026, United States Antimony Corporation announced it would release fiscal year 2025 financial and operating results after U.S. markets close on Thursday, March 19, 2026. The company said senior management would host a conference call and webcast at 4:15 p.m. Eastern time that day to discuss the results, with a replay available afterward, signaling an upcoming update on performance for investors and other stakeholders.
US Antimony, which positions itself as the only fully integrated antimony company outside China and Russia and a key supplier of critical minerals, highlighted its diversified product mix across antimony derivatives, zeolite, and precious metals. The planned disclosure of full-year results comes as the company continues efforts begun in 2024 and 2025 to secure additional mining claims in North America, aimed at reducing reliance on third-party ore and broadening its product offerings.
The most recent analyst rating on (UAMY) stock is a Buy with a $13.50 price target. To see the full list of analyst forecasts on United States Antimony stock, see the UAMY Stock Forecast page.
On March 6, 2026, United States Antimony Corporation announced that the New York Stock Exchange had approved the uplisting of its common stock from NYSE American to the NYSE, where it will continue to trade under the ticker UAMY. Trading on the NYSE is expected to begin on or about March 11, 2026, while the shares will remain listed on the NYSE Texas Exchange under the same symbol.
The uplisting is positioned by the company as a key step toward deepening its institutional and retail shareholder base through access to a larger exchange, a new market-making specialist, and enhanced trading characteristics. Existing shareholders are not required to take any action ahead of the move, and trading on NYSE American will cease once the NYSE listing becomes effective.
The most recent analyst rating on (UAMY) stock is a Buy with a $13.50 price target. To see the full list of analyst forecasts on United States Antimony stock, see the UAMY Stock Forecast page.
United States Antimony has furnished new investor presentation materials outlining its strategy to expand a secure North American antimony supply chain and highlight its unique position as the only fully integrated producer in the region. The materials emphasize the company’s operational platform, including permitted smelters in Montana and Mexico and growing mining and processing capabilities in North America.
The presentation also details global supply constraints driven by China and Russia’s dominance in antimony, rising prices since 2024–2025, and USAC’s efforts to leverage this backdrop through international ore supply partnerships in Chad, Peru, Australia and Bolivia and the restart of its Madero smelter. These disclosures, provided in connection with a current report filing, are explicitly characterized as informational and non‑filed, and are accompanied by extensive cautionary language regarding forward‑looking statements and associated risks for investors.
The most recent analyst rating on (UAMY) stock is a Buy with a $11.00 price target. To see the full list of analyst forecasts on United States Antimony stock, see the UAMY Stock Forecast page.
On February 10, 2026, United States Antimony Corporation announced a joint venture with Americas Gold and Silver Corporation to build and operate a state-of-the-art hydrometallurgical processing facility in Idaho, adjacent to Americas’ active silver, copper, and antimony mines. The venture, owned 51% by Americas and 49% by US Antimony with US Antimony as managing member, aims to improve control, recoveries, and costs for processing copper, silver, and antimony from Americas’ operations.
The Idaho site already holds key environmental and dam safety permits, allowing construction planning to begin immediately and positioning the project as the first commercial-scale hydromet processing center of its kind in North America, using technology exclusively licensed to US Antimony. Executives from both companies framed the deal as a “made in the USA” mine-to-finished-product antimony solution that enhances Americas’ downstream antimony exposure, accelerates U.S. critical mineral capacity, and is intended to create additional value for shareholders by capturing processing profits that previously went unrealized.
The most recent analyst rating on (UAMY) stock is a Hold with a $10.00 price target. To see the full list of analyst forecasts on United States Antimony stock, see the UAMY Stock Forecast page.
On January 28, 2026, United States Antimony Corporation announced that since mid-2025 it has been funding and assisting the development of a commercial-scale hydrometallurgical processing facility in Bolivia to refine antimony and other critical minerals, expanding the plant’s size and output fifteenfold and securing an exclusive contract to receive its antimony flake. The first shipment of roughly 150 tons is expected to reach USAC’s newly expanded Thompson Falls, Montana smelter in February–March 2026, which management says should significantly boost throughput and enable production that meets military specifications, reinforcing the company’s position as the only fully integrated antimony producer outside China and Russia; USAC has also filed a $44 million funding request with the U.S. Department of Energy and is preparing a separate application to the Department of War to support additional state-of-the-art hydromet facilities in North America based on the Bolivian-developed hydromet process, underscoring its push to lead in critical mineral processing for industrial and U.S. government customers.
The most recent analyst rating on (UAMY) stock is a Buy with a $11.00 price target. To see the full list of analyst forecasts on United States Antimony stock, see the UAMY Stock Forecast page.
On January 20, 2026, United States Antimony Corporation announced that it had closed, on January 16, 2026, the $4.75 million cash acquisition of a fully operational critical minerals flotation facility in Radersburg, Montana, with a further $2 million budgeted for equipment upgrades, positioning the asset within 250 miles of its expanding Thompson Falls smelter. The Radersburg Mill, equipped with gravity and flotation circuits capable of concentrating antimony-bearing stibnite as well as gold, silver, copper, and other metals, is intended to process raw ore from Alaska and Montana and replace a previously cancelled lease of a similar Montana facility, strengthening USAC’s integrated supply chain, enhancing its ability to meet industrial and government demand for antimony products, and providing additional milling opportunities to support profitability and operational control.
The most recent analyst rating on (UAMY) stock is a Hold with a $8.50 price target. To see the full list of analyst forecasts on United States Antimony stock, see the UAMY Stock Forecast page.
In a January 5, 2026 letter reviewing performance in calendar year 2025, United States Antimony reported a 182% rise in its share price and a 250% increase in market capitalization, alongside a surge in liquidity from $18.2 million to about $90 million and record revenues and cash flow through the first three quarters. Full‑year revenues climbed from $14.9 million in 2024 to roughly $39 million in 2025, driven mainly by higher pricing on antimony and zeolite, while the company expanded its asset base with new antimony and tungsten leases, issued a long‑life zeolite reserve report, restarted its Madero smelter, and advanced expansion of its Thompson Falls smelter. US Antimony also secured two major five‑year contracts worth more than $350 million in aggregate—one with the U.S. Defense Logistics Agency to replenish the National Defense Stockpile and another with an industrial customer for fire‑retardant materials—completed $69.2 million of equity offerings, dual‑listed its shares, and broadened its investor base to about 30% institutional ownership. Management emphasized that the company has become a fully integrated antimony producer outside China and Russia and highlighted that future growth in 2026 is expected to come primarily from higher production volumes supported by increased ore procurement and mining, signaling a strengthening competitive position in the North American critical minerals sector and a deeper alignment with U.S. defense and industrial supply chain needs.
The most recent analyst rating on (UAMY) stock is a Hold with a $6.50 price target. To see the full list of analyst forecasts on United States Antimony stock, see the UAMY Stock Forecast page.